[Problem of intraoperative hemotransfusion].

Area of Science:

• Medical research
• Hematology
• Critical care medicine

Context:

• Hemorrhagic shock is a life-threatening condition requiring timely and effective intervention.
• Optimizing oxygen delivery and tissue perfusion is critical in managing hemorrhagic shock.
• Current transfusion practices require further evaluation for efficacy in specific shock stages.

Purpose:

• To evaluate the efficacy of low-volume erythrocyte mass transfusion in treating hemorrhagic shock II.
• To determine the optimal timing and storage conditions for erythrocyte mass transfusions in this patient cohort.
• To assess the impact of transfusion therapy on tissue oxygenation and bone marrow stimulation.

Summary:

• A study involving 66 male patients with hemorrhagic shock II investigated blood gas composition and detailed blood analysis before and after hemotransfusion.
• Results indicate that low-volume (up to 2 doses) erythrocyte mass transfusion, stored for up to 3 days and administered after bleeding cessation and hypovolemia correction, is the most effective treatment.
• Substitution therapy in the operating room without addressing hypovolemia was found to be ineffective for oxygen transfer and potentially detrimental due to hypoxia, inhibiting bone marrow stimulation.

Impact:

• Findings suggest a refined protocol for transfusion therapy in hemorrhagic shock, emphasizing volume, storage, and timing.
• This research could lead to improved patient outcomes by optimizing oxygen transport and mitigating adverse effects of inappropriate substitution therapy.
• The study highlights the importance of addressing hypovolemia concurrently with or prior to transfusion for effective treatment of hemorrhagic shock.